Literature DB >> 9684855

Mosaic Qbeta coats as a new presentation model.

I Vasiljeva1, T Kozlovska, I Cielens, A Strelnikova, A Kazaks, V Ose, P Pumpens.   

Abstract

The new protein carrier was developed on the basis of recombinant RNA phage Qbeta capsid. C-terminal UGA extension of the short form of Qbeta coat, so-called A1 extension, served as a target for presentation of foreign peptides on the outer surface of mosaic Qbeta particles. In conditions of enhanced UGA suppression, the proportion of A1-extended to short coats in mosaic particles dropped from 48% to 14%, with an increase of the length of A1 extension. A model insertion, short preS1 epitope 31-DPAFR-35 of hepatitis B surface antigen, demonstrated superficial location on the mosaic Qbeta particles and ensured specific antigenicity and immunogenicity.

Mesh:

Substances:

Year:  1998        PMID: 9684855     DOI: 10.1016/s0014-5793(98)00716-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

1.  In vitro evolution and affinity-maturation with Coliphage qβ display.

Authors:  Claudia Skamel; Stephen G Aller; Alain Bopda Waffo
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

2.  Cell targeting with hybrid Qβ virus-like particles displaying epidermal growth factor.

Authors:  Jonathan K Pokorski; Marisa L Hovlid; M G Finn
Journal:  Chembiochem       Date:  2011-09-29       Impact factor: 3.164

3.  Plasma clearance of bacteriophage Qbeta particles as a function of surface charge.

Authors:  Duane E Prasuhn; Pratik Singh; Erica Strable; Steven Brown; Marianne Manchester; M G Finn
Journal:  J Am Chem Soc       Date:  2008-01-05       Impact factor: 15.419

4.  Surface functionalization of virus-like particles by direct conjugation using azide-alkyne click chemistry.

Authors:  Kedar G Patel; James R Swartz
Journal:  Bioconjug Chem       Date:  2011-02-28       Impact factor: 4.774

5.  Crystal structure of the read-through domain from bacteriophage Qβ A1 protein.

Authors:  Janis Rumnieks; Kaspars Tars
Journal:  Protein Sci       Date:  2011-08-18       Impact factor: 6.725

Review 6.  Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases.

Authors:  Pan Tao; Jingen Zhu; Marthandan Mahalingam; Himanshu Batra; Venigalla B Rao
Journal:  Adv Drug Deliv Rev       Date:  2018-07-06       Impact factor: 15.470

7.  Assembly of hybrid bacteriophage Qbeta virus-like particles.

Authors:  Steven D Brown; Jason D Fiedler; M G Finn
Journal:  Biochemistry       Date:  2009-12-01       Impact factor: 3.162

8.  Engineered mutations change the structure and stability of a virus-like particle.

Authors:  Jason D Fiedler; Cody Higginson; Marisa L Hovlid; Alexander A Kislukhin; Alexandra Castillejos; Florian Manzenrieder; Melody G Campbell; Neil R Voss; Clinton S Potter; Bridget Carragher; M G Finn
Journal:  Biomacromolecules       Date:  2012-07-25       Impact factor: 6.988

9.  Strategic approach to produce low-cost, efficient, and stable competitive internal controls for detection of RNA viruses by use of reverse transcription-PCR.

Authors:  Gabriela V Villanova; Daniela Gardiol; Miguel A Taborda; Virginia Reggiardo; Hugo Tanno; Emilia D Rivadeneira; Germán R Perez; Adriana A Giri
Journal:  J Clin Microbiol       Date:  2007-08-15       Impact factor: 5.948

10.  Unnatural amino acid incorporation into virus-like particles.

Authors:  Erica Strable; Duane E Prasuhn; Andrew K Udit; Steven Brown; A James Link; John T Ngo; Gabriel Lander; Joel Quispe; Clinton S Potter; Bridget Carragher; David A Tirrell; M G Finn
Journal:  Bioconjug Chem       Date:  2008-03-05       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.